This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Menyanthes trifoliata
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
Aquatic plant of boggy areas in northern hemisphere; traditional bitter tonic and rheumatic remedy.
Aquatic plant of boggy areas in northern hemisphere; traditional bitter tonic and rheumatic remedy. Key active compounds include menyanthine, foliamenthin, loganin.
menyanthine, along with foliamenthin and loganin, are the primary bioactive compounds in Menyanthes trifoliata. These compounds modulates NF-κB and COX-2 inflammatory pathways, provides free radical scavenging activity.
Anti-inflammatory
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Bitter tonic
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Antioxidant
Diuretic
Rheumatism
Based on traditional use; clinical evidence limited
Digestive bitters
Based on traditional use; clinical evidence limited
Liver support
Based on traditional use; clinical evidence limited
Fever
Based on traditional use; clinical evidence limited
Found an error or have a correction for Menyanthes trifoliata?
Report an Issue →